HomeCompareCYBQY vs SBUX

CYBQY vs SBUX: Dividend Comparison 2026

CYBQY yields 122.25% · SBUX yields 2.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CYBQY wins by $9.14M in total portfolio value
10 years
CYBQY
CYBQY
● Live price
122.25%
Share price
$1.64
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9.30M
Annual income
$3,564,642.24
Full CYBQY calculator →
SBUX
SBUX
● Live price
2.75%
Share price
$89.59
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$157.5K
Annual income
$65,840.13
Full SBUX calculator →

Portfolio growth — CYBQY vs SBUX

📍 CYBQY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCYBQYSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CYBQY + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CYBQY pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYBQY
Annual income on $10K today (after 15% tax)
$10,391.20/yr
After 10yr DRIP, annual income (after tax)
$3,029,945.90/yr
SBUX
Annual income on $10K today (after 15% tax)
$233.40/yr
After 10yr DRIP, annual income (after tax)
$55,964.11/yr
At 15% tax rate, CYBQY beats the other by $2,973,981.79/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYBQY + SBUX for your $10,000?

CYBQY: 50%SBUX: 50%
100% SBUX50/50100% CYBQY
Portfolio after 10yr
$4.73M
Annual income
$1,815,241.18/yr
Blended yield
38.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

CYBQY
No analyst data
Altman Z
3.4
Piotroski
2/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+16.1% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYBQY buys
0
SBUX buys
0
No recent congressional trades found for CYBQY or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCYBQYSBUX
Forward yield122.25%2.75%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$9.30M$157.5K
Annual income after 10y$3,564,642.24$65,840.13
Total dividends collected$8.47M$127.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: CYBQY vs SBUX ($10,000, DRIP)

YearCYBQY PortfolioCYBQY Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$22,925$12,224.94$11,107$407.21+$11.8KCYBQY
2$50,722$26,192.15$12,512$626.87+$38.2KCYBQY
3$108,432$54,159.43$14,366$978.69+$94.1KCYBQY
4$224,228$108,206.16$16,929$1,557.50+$207.3KCYBQY
5$449,047$209,122.98$20,658$2,543.80+$428.4KCYBQY
6$871,879$391,399.02$26,406$4,302.22+$845.5KCYBQY
7$1,643,143$710,232.38$35,877$7,622.00+$1.61MCYBQY
8$3,009,101$1,250,937.80$52,741$14,352.64+$2.96MCYBQY
9$5,360,722$2,140,983.26$85,676$29,243.03+$5.28MCYBQY
10$9,300,614$3,564,642.24$157,513$65,840.13+$9.14MCYBQY

CYBQY vs SBUX: Complete Analysis 2026

CYBQYStock

CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains equipment and systems for medical and warfare in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high speed light pulse LED array light source that enables real time photoacoustic imaging. It also provides Cybernics Treatment, a treatment that uses HAL to enhance/regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; HAL FIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes' brain-nerve functions; and Neuro HALFIT for enhancement of physical functions. In addition, the company is involved in the provision of rescue supports in disaster sites, and heavy labor supports for factories and plants; and entertainment business. The company was incorporated in 2004 and is headquartered in Tsukuba, Japan.

Full CYBQY Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this CYBQY vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYBQY vs SCHDCYBQY vs JEPICYBQY vs OCYBQY vs KOCYBQY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.